Precision BioSciences, Inc. (DTIL) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Number of PBGENE-HBV Doses Administered | 38.00 | FY2026-Q2 |
| Number of Patients Dosed in Phase 1 ELIMINATE-B (PBGENE-HBV) | 16.00 | FY2026-Q1 |
Back to DTIL overview · DTIL earnings · DTIL holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.